An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...
Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.
In the US, diagnosed prevalence is anticipated to increase across all opioid addiction patient segments. Credit: Iryna Imago ...
The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which has previously attempted to block Lumryz’s ...
A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan ...
An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...
With less than three weeks until Americans cast their vote, what would healthcare look under a Harris or Trump administration ...
A potential three-year framework agreement between the Greek government and the pharmaceutical industry, starting at the ...
The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback